2. Signaling Pathways
  3. Epigenetics
  4. Glycosyltransferase
  5. Glycosyltransferase Inhibitor

Glycosyltransferase Inhibitor

Glycosyltransferase Inhibitors (4):

Cat. No. Product Name Effect Purity
  • HY-107366
    SGN-2FF
    		Inhibitor ≥98.0%
    SGN-2FF is a potent and orally active inhibitor of fucosylation, directly inhibits fucosyltransferase activity. SGN-2FF possesses antitumor activity.
  • HY-139056
    SU0268
    		Inhibitor 99.96%
    SU0268 is a potent and specific inhibitor of 8-Oxoguanine DNA glycosylase 1 (OGG1). SU0268 regulates inflammatory responses during Pseudomonas aeruginosa infection.
  • HY-169084
    ST-IN-1
    		Inhibitor
    ST-IN-1 (compound (R)-1) is a selective ST inhibitor (Ki=70 nM, rat a-2,6-ST; Ki=19 nM, hST6GAL1) with antitumor activity. ST-IN-1 inhibits tumor growth and metastasis by delipidating the surface of tumor cells.
  • HY-147960
    Glycosyltransferase-IN-1
    		Inhibitor
    Glycosyltransferase-IN-1 (compound 5m) is a potent glycosyltransferase inhibitor, with an IC50 of 82.8 μM. Glycosyltransferase-IN-1 shows antibacterial activity, with MIC values of 6 μg/mL for MSSA, MRSA, B. subtilis and 12 μg/mL for E. coli.